New preclinical findings provide validation for Silexion’s new systemic administration approach for SIL-204, demonstrating ...

The addition of high-dose IV vitamin C to standard chemotherapy nearly doubled OS for patients with advanced pancreatic cancer, according to results of a randomized phase 2 trial.Vitamin C also ...

Silexion Therapeutics Corp. (NASDAQ:SLXN) released new preclinical data for SIL-204, its next-generation siRNA therapeutic ...

Silexion Therapeutics (SLXN) announced new preclinical data for SIL-204, its next-generation siRNA therapeutic candidate. The findings ...

Russia’s Gamaleya Research Institute, known for developing the Sputnik V COVID-19 vaccine, is close to gaining regulatory ...

CAYMAN ISLANDS - Silexion Therapeutics Corp. (NASDAQ: SLXN), a biotech firm focusing on RNA interference (RNAi) treatments, ...

Cancer clinical trials lack diversity, with white patients overrepresented and minorities, women, and the elderly ...

Recent trends reveal a sharp rise in cancer cases in India, with younger patients and a lack of effective screening programs ...

The decline in cancer incidence among men and increase among women has narrowed the male‐to-female cancer incidence rate ratio from a peak of 1.6 in 1992 to 1.1 in 2021. In people aged 50-64 years, ...

An observational analysis has found that the drugs may lower the risk of substance abuse and cognitive issues. But the ...

Scientists have characterized the role of thousands of mutations in the BRCA2 cancer gene, findings that may help reassure ...

Cancer mortality has increased in the last decade, with 8,140 cases compared to 6,278 in 2014. The report 'The figures of ...